Hormonal
Adiposity (body fat percentage) does not significantly modify the acute or chronic appetite and energy intake responses to exercise, meaning exercise is equally effective for appetite regulation in lean and overweight/obese individuals.
Your body weight does not determine how well exercise works for regulating your appetite. Whether you are lean or have overweight/obesity, exercise will similarly suppress your appetite temporarily and not trigger compensatory overeating. This makes exercise a universally applicable tool for energy balance.
the balance of evidence suggests that adiposity and sex do not modify appetite or energy intake responses to acute or chronic exercise interventions
Why this rating
The paper states 'the balance of evidence suggests' this, citing multiple studies with consistent findings on appetite/energy intake, though hormonal responses vary.
Source
Acute and Chronic Effects of Exercise on Appetite, Energy Intake, and Appetite-Related Hormones: The Modulating Effect of Adiposity, Sex, and Habitual Physical Activity
James L. Dorling et al. · Nutrients · 2018
DOI 10.3390/nu10091140
More from this paper
- Acute exercise induces a transient suppression of appetite (exercise-induced anorexia) and does not stimulate compensatory increases in energy intake on the day of exercise, regardless of whether the individual is lean or has overweight/obesity.Good
- Chronic exercise training improves the sensitivity of the appetite control system, specifically by enhancing the satiety response to high-energy meals, independent of changes in body fat.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →